Medwin Impex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 34.08%
- Profit Growth 8.30%
- Ebitda -124.48%
- Net Worth 13.55%
- Total Assets 18.21%
About Medwin Impex
Medwin Impex Private Limited (MIPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2010 and has a history of 14 years and 11 months. Its registered office is in Karnal, Haryana, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Kumar and Shashi Kajal serve as directors at the Company.
Company Details
- Location
Karnal, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51900HR2010PTC040220
- Company No.
040220
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Medwin Impex?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Kumar  | Director | 08-Nov-2011 | Current |
| Shashi Kajal | Director | 15-Jun-2022 | Current |
Financial Performance of Medwin Impex.
Medwin Impex Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.08% increase. The company also saw a slight improvement in profitability, with a 8.3% increase in profit. The company's net worth Soared by an impressive increase of 13.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medwin Impex?
Unlock access to Medwin Impex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Index Oil & Chemicals Private LimitedRajesh Kumar is a mutual person
- Winmax Healthcare Private Limited
Rajesh Kumar is a mutual person
- Merz Bioceuticals Private Limited
Rajesh Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medwin Impex?
Unlock and access historical data on people associated with Medwin Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medwin Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medwin Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
